No abstract available
Publication types
-
Comment
-
Editorial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Benzamides
-
Drug Resistance, Neoplasm
-
Fusion Proteins, bcr-abl
-
Genes, abl*
-
Humans
-
Imatinib Mesylate
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
-
Piperazines / therapeutic use*
-
Protein Kinase Inhibitors / therapeutic use*
-
Protein-Tyrosine Kinases / antagonists & inhibitors
-
Protein-Tyrosine Kinases / genetics
-
Protein-Tyrosine Kinases / metabolism
-
Pyrimidines / therapeutic use*
-
Stem Cells / drug effects
-
Stem Cells / physiology*
Substances
-
Benzamides
-
Piperazines
-
Protein Kinase Inhibitors
-
Pyrimidines
-
Imatinib Mesylate
-
Protein-Tyrosine Kinases
-
Fusion Proteins, bcr-abl